Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs directed at increasing the horizons of cytokine-based immunotherapy, especially for cancers where procedure selections remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/littio-expands-euro-access-for-latin-americans-amid-inflation-concerns/